Perrigo Company plc APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
Perrigo Company plc (PRGO) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $900.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2024-02-27.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2024-02-27
- Perrigo Company plc apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2021-10-02 was $200.00K, a 50.00% decline year-over-year.
- Perrigo Company plc apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2021-07-03 was $200.00K, a 50.00% decline year-over-year.
- Perrigo Company plc apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2021-04-03 was $400.00K, a 50.00% decline year-over-year.
- Perrigo Company plc apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2020-09-26 was $400.00K, a 55.56% decline year-over-year.
- Perrigo Company plc apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2021 was $900.00K, a 55.00% decline from fiscal 2020.
- Perrigo Company plc apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2020 was $2.00M, a 57.45% decline from fiscal 2019.
- Perrigo Company plc apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2019 was $4.70M, a 41.98% decline from fiscal 2018.
- Perrigo Company plc apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2018 was $8.10M, a 8.99% decline from fiscal 2017.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2021-12-31 | $900.00K 10-K · filed 2024-02-27 | |||
| 2021-10-02 | $200.00K 10-Q · filed 2022-11-08 | $400.00K derived: sum of 2 quarters · filed 2022-11-08 | $800.00K derived: sum of 3 quarters · filed 2022-11-08 | |
| 2021-07-03 | $200.00K 10-Q · filed 2022-11-08 | $600.00K derived: sum of 2 quarters · filed 2022-11-08 | ||
| 2021-04-03 | $400.00K 10-Q · filed 2022-11-08 | |||
| 2020-12-31 | $2.00M 10-K · filed 2023-02-28 | |||
| 2020-09-26 | $400.00K 10-Q · filed 2021-11-12 | $800.00K derived: sum of 2 quarters · filed 2021-11-12 | $1.60M derived: sum of 3 quarters · filed 2021-11-12 | |
| 2020-06-27 | $400.00K 10-Q · filed 2021-11-12 | $1.20M derived: sum of 2 quarters · filed 2021-11-12 | ||
| 2020-03-28 | $800.00K 10-Q · filed 2021-11-12 | |||
| 2019-12-31 | $4.70M 10-K · filed 2022-03-01 | |||
| 2019-09-28 | $900.00K 10-Q · filed 2020-11-05 | $2.20M derived: sum of 2 quarters · filed 2020-11-05 | $4.00M derived: sum of 3 quarters · filed 2020-11-05 | |
| 2019-06-29 | $1.30M 10-Q · filed 2020-11-05 | $3.10M derived: sum of 2 quarters · filed 2020-11-05 | ||
| 2019-03-30 | $1.80M 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $8.10M 10-K · filed 2021-03-01 | |||
| 2018-09-29 | $500.00K 10-Q · filed 2019-11-06 | $3.20M derived: sum of 2 quarters · filed 2019-11-06 | $5.90M derived: sum of 3 quarters · filed 2019-11-06 | |
| 2018-06-30 | $2.70M 10-Q · filed 2019-11-06 | $5.40M derived: sum of 2 quarters · filed 2019-11-06 | ||
| 2018-03-31 | $2.70M 10-Q · filed 2019-11-06 | |||
| 2017-12-31 | $8.90M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $5.00M 10-K · filed 2019-02-27 | |||
| 2015-12-31 | $2.50M 10-K · filed 2018-03-01 | |||
| 2015-06-27 | $6.90M 10-K · filed 2018-03-01 | |||
| 2014-06-28 | $6.50M 10-K · filed 2017-05-22 | |||
| 2013-06-29 | $6.10M 10-KT · filed 2016-02-25 | |||
| 2012-06-30 | $5.00M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |